Source: Epilepsy Therapy Project
Wednesday, March 17, 2010
2010 Presentations Webcast Available at www.epilepsy.com
advertisement
MIDDLEBURG, Va., March 17 /PRNewswire-USNewswire/ -- The Epilepsy Therapy Project (ETP), a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments. The 2010 conference featured a stellar line up of leading drug and device developers, investigators and industry leaders who showcased the newest epilepsy therapies in development. The presentation webcasts have been posted online at http://www.epilepsy.com/etp/pipeline2010_webcasts.
"The current Epilepsy Therapy Pipeline demonstrates both progress and necessity for resources and collaboration to speed clinical development. Epilepsy affects as many people as breast cancer or Alzheimer's disease, and still one million children and adults continue to have seizures despite available treatment," said Warren Lammert, ETP Founder and Chairman. "We are gratified that the Epilepsy Pipeline Update Conference 2010 conference has grown to attract an impressive audience and companies are recognizing the need for and promise in developing potential new therapeutics to address the billion dollar epilepsy market."
"Through this conference and ETP's own funding, matching and networking efforts, we hope to help bridge critical stages of development, and to identify and advocate for highly competitive pipeline programs that should be accelerated through development and to the patient. We constantly monitor innovation and clinical progress in the epilepsy and CNS field to seek out deserving, high-value programs and we are dedicated to making this research available through our conference and also now online at www.epilepsy.com," said Joyce Cramer, President.
The Epilepsy Therapy Pipeline programs featured in 2010 include some of the most innovative therapies in development today for epilepsy including a review of products from public companies such as Cyberonics, Eisai, Johnson & Johnson, King Pharmaceuticals, Lundbeck, Medtronic, Sepracor, Valeant Pharmaceuticals and UCB, as well as private companies such as Advanced Neurometrics, Marinus Pharmaceuticals, NeuroPace, NeuroTherapeutics, NeuroVista, Supernus Pharmaceuticals and Visualase. Presentations included updates on:
Pipeline Presentations and Access to Expert Talks at
www.epilepsy.com
In addition to the company presentations, leading experts in epilepsy addressed issues related to the development of important new therapies:
The agenda for the full program and webcasts of presentations may be seen at http://www.epilepsy.com/etp/pipeline2010_webcasts.
About the Epilepsy Therapy Project
The Epilepsy Therapy Project is a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy. Founded in 2002 by a group of parents, distinguished physicians and researchers, the Epilepsy Therapy Project supports the commercialization of new therapies through direct grants and investments in promising academic and commercial projects. Learn more at www.epilepsy.com.
CONTACT: Joyce Cramer, President, Epilepsy Therapy Project,
+1-713-552-0289, joyce@epilepsytherapyproject.org; or Susan Pietropaolo,
BCC Partners, +1-845-638-6290, spietropaolo@bccpartners.com
Web site: http://www.epilepsy.com/